Dulaglutide Insurance Coverage
Trulicity has excellent insurance coverage for type 2 diabetes. Most commercial and Medicare plans cover it. Savings card brings cost to $25/month.
Commercial coverage
Excellent
Medicare Part D
Widely covered
Typical copay
$25-75/mo
Savings card
$25/mo minimum
Step therapy
Often preferred first
Strong Formulary Position
Trulicity has one of the strongest insurance coverage profiles among GLP-1 medications. It's on the formulary of virtually all major commercial plans and Medicare Part D for type 2 diabetes. Many PBMs have designated it as a preferred GLP-1, sometimes requiring step therapy through Trulicity before covering newer options like Mounjaro or Ozempic.
Typical copays with commercial insurance range from $25-$75/month, making it one of the most affordable brand GLP-1 medications for insured patients.
Savings and Assistance
The Trulicity Savings Card reduces copays to as low as $25/month for eligible commercially insured patients. Eli Lilly's patient assistance program provides free medication for qualifying uninsured patients meeting income criteria.
For cash-pay patients, Trulicity's pricing ($900-$1,100/month) is comparable to other GLP-1 medications. However, its strong insurance coverage means most patients access it at significantly reduced copays.
Frequently Asked Questions
Is Trulicity covered by most insurance plans?
Yes, Trulicity has excellent coverage for type 2 diabetes across virtually all major commercial plans and Medicare Part D. It's often a preferred GLP-1 with lower copays than newer alternatives.
Does Medicare cover Trulicity?
Yes, Medicare Part D covers Trulicity for type 2 diabetes. Copays vary by plan but are generally affordable with the Trulicity Savings Card.
Find the most cost-effective GLP-1 medication for your plan
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Dulaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.